Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this prospective, observational study is the evaluation of the effectiveness of a 14-day Specialist Palliative Care therapy in participants with advanced breast cancer carried out in a stationary palliative care unit in Poland. The length of the entire study will be 36 months.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| patients under the age of 65 years | patients under the age of 65 years |
| |
| patients at the age of 65 years and over | patients at the age of 65 years and over |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Specialist Palliative Care | Procedure | In the research, Specialist Palliative Care was provided according to the guidelines established by Mid-Western Health Board in a Report of the National Advisory Committee on Palliative Care as well as according to recommendations of Polish Society of Palliative Medicine and Polish National Healthcare Fund. In order to ensure interdisciplinary and integrated palliative care, a team of specialists was appointed. Team members were engaged in the process of treatment of each patient during the time of the study and applied their specialist skills according to the needs of the patients |
| Measure | Description | Time Frame |
|---|---|---|
| Variation of intensification of patients negative symptoms before and after SPC | intensification of patients negative symptoms was assessed by Edmonton Symptom Assessment System (esas) | 14 days |
| Variation of performance status of patients before and after SPC | performance status of patients was assessed by ECOG scale (Eastern Cooperative Oncology Group) | 14 days |
| Variation of quality of life of patients before and after SPC | quality of life of patients of patients was assessed by quality of life uniscale (QoLU) | 14 days |
Not provided
Not provided
Inclusion Criteria:
the patient's conscious consent for examination and the ability to fill in the form by the patient herself.
-
Exclusion Criteria:
Not provided
Not provided
Patients with advanced stage breast cancer refered for a SPC treatment at palliative care department in Poland, Będzin.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jadwiga Jośko-Ochojska, prof | 4. Chair and Department of Medicine and Environmental Epidemiology Medical University of Silesia in Katowice | Study Chair |
| Łukasz Pietrzyńsi | 1. Medical University of Silesia, department of palliative medicine | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Aug 2, 2018 | |
| Reset | Jan 17, 2019 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Aug 2, 2018 | Jan 17, 2019 |
| ID | Term |
|---|---|
| D001943 | Breast Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| D017437 |
| Skin and Connective Tissue Diseases |